Complexity in radiological morphology predicts worse prognosis and is associated with an increase in proteasome component levels in clear cell renal cell carcinoma

Kohei Kobatake; Kenichiro Ikeda; Jun Teishima; Yohei Sekino; Takashi Babasaki; Yuki Kohada; Ryo Tasaka; Kenshiro Takemoto; Takafumi Fukushima; Shunsuke Miyamoto; Hiroyuki Kitano; Keisuke Goto; Keisuke Hieda; Tetsutaro Hayashi; Nobuyuki Hinata

doi:10.3389/fonc.2022.1039383

Complexity in radiological morphology predicts worse prognosis and is associated with an increase in proteasome component levels in clear cell renal cell carcinoma

Front Oncol. 2022 Dec 8:12:1039383. doi: 10.3389/fonc.2022.1039383. eCollection 2022.

Authors

Affiliations

¹ Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
² Department of Urology, Kobe City Hospital Organization Kobe City Medical Center West Hospital, Kobe, Japan.

Abstract

Background: We previously reported preoperative radiological morphology (RM) as an independent predictor for pathological upstaging after partial nephrectomy in patients with T1 renal cell carcinoma (RCC).

Purpose: To investigate the prognostic importance of RM in all stages and the molecular characteristics underlying the differences between each type of RM in patients with clear cell RCC (ccRCC).

Design setting and participants: The Cancer Imaging Archive datasets (TCIA), comprising CT images and RNA-sequencing data, were used (n = 163). Specimens from 63 patients with ccRCC at our institution and their CT images were used. All images were divided into three types according to RM classification.

Outcome measurements and statistical analysis: Relationships with outcome were analyzed using Cox regression analysis and log-rank test.

Results and limitations: The irregular type was a significant independent predictor of worse disease-free survival (odds ratio: 2.22, p = 0.037) compared to round and lobular types in TCIA datasets. The irregular type showed a significant increase in both mRNA and protein expression of proteasome components, PSMB1 and PSMB3. Moreover, high expression of their coding genes shortened the progression-free survival of the patients with ccRCC who received sunitinib or avelumab plus axitinib therapy. The study limitations include the qualitative classification of RM and the need for novel radiomics and texture analysis techniques.

Conclusions: Investigating RM on pre-treatment CT scans can effectively predict worse prognosis. Increased RM complexity may indirectly predict drug sensitivity via increased expression of PSMB1 and PSMB3 in patients with ccRCC. Specific targeting of the ubiquitin-proteasome system might be a novel treatment strategy for ccRCC with increased RM complexity.

Patient summary: The clinical and morphological characteristics of patients with ccRCC vary greatly according to cancer staging. In this study, we built upon our prior findings of the prognostic importance of RM in T1 RCC and expanded it to encompass all stages of RCC, using a series of patients from a Japanese hospital.

Keywords: PSMB1; PSMB3; clear cell renal cell carcinoma; proteosome; radiological morphology; renal cell carcinoma (RCC).